Neurostatus-UHB is the leading provider of expertise in the standardized neurological assessment of clinical symptoms in Multiple Sclerosis and related neurological disorders.
We support clinical trials and academic studies with licensing and digital solutions around the Expanded Disability Status Scale (Neurostatus-EDSS) and develop innovative solutions to improve the reliability of clinical data.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Gerbergasse 16, Basel,basel-Stadt 4001,switzerland
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://neurostatus-uhb.com/
- Keywords
- for assessing clinical symptoms in people with multiple sclerosis (MS) and neurological disorders".
- HQ
- Basel, Basel-Stadt
Neurostatus-Uhb Ag Questions
Neurostatus-Uhb Ag's website is https://neurostatus-uhb.com/
Neurostatus-Uhb Ag's LinkedIn profile is https://ch.linkedin.com/company/neurostatus-uhb-ag
Neurostatus-Uhb Ag has
12 employees.
View email and phone details for 12
employees at Neurostatus-Uhb Ag.
Neurostatus-Uhb Ag's industry is
Hospitals and Health Care
Neurostatus-Uhb Ag's top competitors are
Syngenta Agro S.a.,
Citytrans Gmbh,
Eggimann Stöckli & Partner,
The Bloc,
University Hospital Basel,
Celonic Group,
Penkov, Markov & Partners,
Scheer Schweiz Ag,
Women In Tech® Switzerland,
Monjon (Australia).
Neurostatus-Uhb Ag's categories are Hospitals and Health Care
Neurostatus-Uhb Ag's founding year is 2022
